The Manila Times

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...
Pharmabiz

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Myriad Genetics, Inc.: Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

Myriad's Diagnostic Test for Ovarian Cancer Treatment Gets FDA Approval

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration.
HRD America

AI is quietly redrawing career paths – and the divide is already visible

New research shows that workers who master everyday AI tools like ChatGPT are earning significantly more, getting promoted ...

24.7 lakh write foundational literacy and numeracy assessment exam across A.P.

Over 24.7 lakh candidates participated in Andhra Pradesh's FLNAT 2026, showcasing impressive attendance and strong administrative support.

‘AI literacy gap could hamper future growth’

IN the high-stakes world of global manufacturing, being "fast" is no longer enough – one also has to be "smart". Read full story ...